Rephonic
Artwork for OncoAlert

OncoAlert

OncoAlert
Prostate Cancer
Clinical Trials
Breast Cancer
Small Cell Lung Cancer
EGFR Mutant Lung Cancer
Multiple Myeloma
Adriatic Study
Ozimertinib
Tarlatumab
Mariposa Trial
FLORA Trial
FLORA2 Trial
Pancreatic Cancer
DLL3
Amivantamab
Lazertinib
Advanced Prostate Cancer
ENFORTE
Colorectal Cancer
Cancer

The latest in Oncology News, happenings and research.

PublishesWeeklyEpisodes17Founded5 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for OncoAlert

Latest Episodes

🚨 Oncología Ahora y en Directo | Avances en Cáncer de Vejiga Avanzado 

En este episodio, las Dras. @nataliagandur 🇦🇷 y @ReginaBarCar 🇲🇽 analizan los avances más recientes en el tratamiento del carcinoma urotelial localmente avanzado y metastási... more

🎙️ Oncology Here & Now Podcast | Season 2, Episode 3

In this episode, we explore HER2-positive advanced breast cancer with a leading experts in the field Dr. Elisa Agostinetto and Dr. Erika Hamilton. We discuss the evolving treatment landscape, inc... more

Join Dr. Gil Morgan in conversation with Mr. Tyler Kratzer of the American Cancer Society, lead author of Prostate Cancer Statistics 2025 (published in CA: A Cancer Journal for Clinicians).

📖 Read the paper here: acsjournals.onlinelibrary.w... more

The OncoAlert Weekly Roundup is your go-to podcast for the latest, most impactful updates in oncology from across the globe 🌍. Each week, we break down the key studies shaping cancer care—so you stay ahead, in just minutes.

This week’s highlights i... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
OncLive® On Air
OncLive® On AirOncLive® On Air

Recent Guests

Tyler Kratzer
Lead author of 'Prostate Cancer Statistics 2025' and associate scientist in surveillance research at the American Cancer Society
American Cancer Society
Episode: Oncology Here and Now with Dr Morgan & Mr Tyler Kratzer.
Dr. Ahmedin Jemal
Distinguished cancer epidemiologist and senior vice president of the Surveillance and Health Equity Science Department at the American Cancer Society
American Cancer Society
Episode: Oncology Here & Now (General Cancer): Cancer Report to the Nation with Dr. Ahmedin Jemal & Dr. Gil Morgan
Marcelo Corassa
A thoracic medical oncologist based in São Paulo, Brazil
BP, Beneficência Portuguesa de São Paulo
Episode: Oncology Here & Now (Lung Cancer): Dr. Marcelo Corassa & Dr. Biaggio Ricciuti discuss FLAURA, MARIPOSA & FLAURA2

Host

Gil Morgan
Host of OncoAlert

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Oncology Here and Now with Dr Morgan & Mr Tyler Kratzer.
Q: Should younger men rethink when to start the conversation about prostate cancer risk and screening?
Yes, discussions about prostate cancer risk and screening should begin around age 50, or earlier for those at higher risk, such as Black men or those with a family history of the disease.
Oncology Here and Now with Dr Morgan & Mr Tyler Kratzer.
Q: What are the important steps that could help close the gap in racial disparities concerning prostate cancer?
Increasing access to high-quality, guideline-concordant treatment for all patients is crucial, alongside raising awareness about underrepresentation in clinical trials.
Oncology Here and Now with Dr Morgan & Mr Tyler Kratzer.
Q: What could be the possible main reasons for the paradox of increasing diagnoses of advanced prostate cancer despite high survival rates?
The overall high survival rate is due to a majority of cases being diagnosed at localized or regional stages, while advanced stage disease, though rising, has yet to heavily impact overall survival rates.
Oncology Here & Now (General Cancer): Cancer Report to the Nation with Dr. Ahmedin Jemal & Dr. Gil Morgan
Q: What does the return of cancer rates to pre-pandemic levels suggest about the adaptability of the healthcare system post-pandemic?
The steep decline in screening was short-lived, with a return to pre-pandemic levels due to effective campaigns by health agencies.
Oncology Here & Now (General Cancer): Cancer Report to the Nation with Dr. Ahmedin Jemal & Dr. Gil Morgan
Q: What key factors do you attribute to the sustained reduction in cancer mortality over the past two decades?
Reduction in tobacco use and improved early detection and treatment.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncoAlert

What is OncoAlert about and what kind of topics does it cover?

The content encompasses a wide range of topics within oncology, focusing primarily on advancements in cancer treatment, current research developments, and significant clinical trial findings. Episodes frequently feature expert discussions on therapies for various cancer types, including breast, prostate, and bladder cancers, as well as insights on health disparities in cancer care, particularly in Latin America. Noteworthy is the emphasis on personalized treatment approaches and accessibility to care, reflecting the ongoing challenges faced in global oncology practice. Listeners can expect to gain valuable insights into both emerging treatments and the practical implications of recent studies, aiming for a more equitable healthcare landscap... more

Where can I find podcast stats for OncoAlert?

Rephonic provides a wide range of podcast stats for OncoAlert. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncoAlert and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncoAlert get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncoAlert, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncoAlert?

Rephonic provides comprehensive predictive audience data for OncoAlert, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncoAlert have?

To see how many followers or subscribers OncoAlert has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncoAlert?

These podcasts share a similar audience with OncoAlert:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. ASCO Daily News
3. OncLive® On Air

How many episodes of OncoAlert are there?

OncoAlert launched 5 years ago and published 17 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncoAlert?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncoAlert?

Rephonic pulls ratings and reviews for OncoAlert from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncoAlert?

Rephonic provides full transcripts for episodes of OncoAlert. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncoAlert?

Recent guests on OncoAlert include:

1. Tyler Kratzer
2. Dr. Ahmedin Jemal
3. Marcelo Corassa

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days